Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vancomycin: a history.

Donald P Levine1

  • 1Department of Medicine, Wayne State University, Detroit, MI 48201, USA. dlevine@med.wayne.edu

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|December 3, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multicenter Cohort Study of Ceftaroline Versus Daptomycin for Treatment of Methicillin-Resistant <i>Staphylococcus aureus</i> Bloodstream Infection.

Open forum infectious diseases·2022
Same author

Validity of 2020 vancomycin consensus recommendations and further guidance for practical application.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2021
Same author

Questions on Vancomycin Dosing.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2020
Same author

Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2020
Same author

Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.

Pharmacotherapy·2020
Same author

Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2020
Same journal

The balance between a new Antibiotic and Non-antibiotic Alternatives for the treatment and prevention of uncomplicated Urinary Tract Infections.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Understanding the Clone-Censor-Weight Method in Observational Studies of Antibiotic Duration.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T Cells.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Protection Against Recurrent Typhoid Fever Conferred by a Prior Episode: Evidence from a Large Cohort Study in Dhaka, Bangladesh.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Pre-treatment Gut Microbiome Diversity and Function Linked to Cytotoxic and Natural Killer Cell Immune Responses after N-803 Treatment in People with HIV.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Reconsidering ambiguous language in infectious disease consult recommendations.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

Vancomycin, once discarded, resurged due to severe infections. Vancomycin resistance and therapeutic utility concerns now drive research into optimal dosing and serum level monitoring for better outcomes.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Microbiology

Background:

  • Vancomycin, an antibiotic, was initially discarded due to perceived toxicity and lower efficacy compared to alternatives.
  • Its use was revived with the rise of pseudomembranous enterocolitis and methicillin-resistant Staphylococcus aureus (MRSA).

Observation:

  • Concerns regarding vancomycin's therapeutic utility and toxicity emerged shortly after its resurgence.
  • The development of vancomycin resistance, initially in enterococci and subsequently in staphylococci, presented significant clinical challenges.

Findings:

  • Multiple types of vancomycin resistance mechanisms have been identified, each impacting treatment efficacy differently.
  • Current research is re-evaluating optimal vancomycin administration strategies.

Related Experiment Videos

Implications:

  • Understanding vancomycin resistance is crucial for managing serious bacterial infections.
  • Future studies may lead to the routine monitoring of serum vancomycin levels to ensure therapeutic success and minimize resistance development.